Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
Clinical trial NCT04772235 · UNKNOWN
Trial details
- NCT number
- NCT04772235
- Sponsor
- Instituto Oncológico Dr Rosell
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2026-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.